Similar articles

• Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.

  Gruber SA, Skjei KL, Sothern RB, Robison L, Tzardis P, Moss A, Gillingham K, Canafax DM, Matas AJ, Dunn DL. Gruber SA, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1104-5. Transplant Proc. 1991. PMID: 1989160 No abstract available.
• Skin cancer after renal transplantation: Results of a multicenter study in Iran.

  Einollahi B, Nemati E, Lessan-Pezeshki M, Simforoosh N, Nourbala MH, Rostami Z, Nafar M, Pourfarziani V, Beiraghdar F, Mahdavi-Mazdeh M, Ahmadpour P, Makhdoomi K, Ghafari A, Ardalan MR, Taebi Khosroshahi H, Oliaei F, Shahidi S, Makhlogh A, Azmandian J, Samimagham HR, Shabazian H. Einollahi B, et al. Ann Transplant. 2010 Jul-Sep;15(3):44-50. Ann Transplant. 2010. PMID: 20877266
• Cancer development in pediatric primary renal allograft recipients.

  Gruber SA, Gillingham K, Sothern RB, Stephanian E, Chavers B, Matas AJ, Dunn DL. Gruber SA, et al. Transplant Proc. 1994 Feb;26(1):3-4. Transplant Proc. 1994. PMID: 8108991 No abstract available.
• [Solid tumors after kidney transplantation].

  Moal MC. Moal MC. Nephrol Ther. 2008 Oct;4 Suppl 3:S214-7. doi: 10.1016/S1769-7255(08)74238-X. Nephrol Ther. 2008. PMID: 19000890 Review. French.
• [Presentation of cancers in recipients of a solid-organ transplant].

  Lampreabe I, Gómez-Ullate P, Amenábar JJ, Zárraga S, Gaínza FJ, Urbizu JM. Lampreabe I, et al. Nefrologia. 2001;21(6):528-37. Nefrologia. 2001. PMID: 11881422 Review. Spanish. No abstract available.